COMMON STOCK PURCHASE WARRANT NKGEN BIOTECH, INC.Security Agreement • May 10th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances)
This COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received (in connection with the issuance of the unsecured promissory note in the principal amount of $220,000.00 to the Holder (as defined below) of even date) (the “Note”), Meteora Select Trading Opportunities Master, LP, Meteora Capital Partners, LP and Meteora Strategic Capital, LLC (including any permitted and registered assigns, collectively, the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from NKGEN BIOTECH, INC., a Delaware corporation (the “Company”), 220,000 shares of Common Stock (the “Warrant Shares”) (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 10th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • Delaware
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 10th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • Delaware
THE PLACEMENT AGENT FOR THIS SECURITIES PURCHASE AGREEMENT IS PROFOR SECURITIES LLC, A DEALER REGISTERED WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION AND IS A MEMBER OF FINRASecurities Purchase Agreement • May 10th, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances) • Nevis
This NOTE has been issued with original issue discount. information regarding the original issue discount may be obtained from the COMPANY (AS DEFINED BELOW).
